Prosperity7 Ventures

Prosperity7 Ventures is the diversified growth fund of Aramco Ventures, headquartered in Dhahran, Saudi Arabia, with approximately $3 billion AUM deploying $5M-$25M cheques at Series A, Series B, Series C, and growth into highly scalable medtech, deep tech, and AI healthcare platforms globally. The firm operates as a strategically patient, financially disciplined growth investor with global mandate and meaningful Saudi government and corporate access. For founders, Prosperity7 is best positioned as a global growth lead with deep pockets and patience, useful for medtech and AI healthcare founders building category-defining platforms with US or international scale ambitions. The right founder profile is a Series A through growth-stage operator (anywhere in the world) building a defensible medtech, AI clinical software, or digital health platform with $10M+ revenue traction, regulatory clearances or clear pathway, and credible international ambition that includes potential Saudi or GCC market entry. Founders running consumer wellness, asset-heavy clinic chains, pre-revenue plays, or single-country LatAm or African boutique propositions are a poor fit. The cleanest entry path is via a Prosperity7 portfolio CEO, sell-side global growth bankers, or warm introductions from US and global growth funds that co-invest. In the pitch, lead with rule-of-40 metrics, regulatory positioning, international expansion strategy with optional GCC angle, and a credible plan for capital efficient growth. Caveats: as an Aramco-affiliated CVC, Prosperity7 weighs strategic alignment alongside financial return, and term sheets may include rights tied to GCC distribution or strategic optionality. Cycle times are institutional and partners expect active board engagement. Confirm reserves and follow-on policy explicitly given the firm’s preference for concentrated growth-stage positions and capacity for follow-on across the lifecycle.